Alpa Laboratories (India) Today
| ALPA Stock | 112.77 0.32 0.28% |
PerformanceVery Weak
| Odds Of DistressLow
|
Alpa Laboratories is selling for under 112.77 as of the 24th of March 2025; that is 0.28 percent increase since the beginning of the trading day. The stock's lowest day price was 111.0. Alpa Laboratories has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 24th of December 2024 and ending today, the 24th of March 2025. Click here to learn more.
Moving together with Alpa Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Alpa Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alpa Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alpa Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman Board | Mahendra Chawla |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Alpa Laboratories Limited (ALPA) is traded on National Stock Exchange of India in India and employs 410 people. Alpa Laboratories is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.41 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alpa Laboratories's market, we take the total number of its shares issued and multiply it by Alpa Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alpa Laboratories operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 21.04 M outstanding shares.
Alpa Laboratories Limited has accumulated about 13.4 M in cash with 36.49 M of positive cash flow from operations.
Check Alpa Laboratories Probability Of Bankruptcy
Ownership AllocationAlpa Laboratories holds a total of 21.04 Million outstanding shares. Alpa Laboratories Limited retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Alpa Ownership Details
Alpa Laboratories Risk Profiles
Although Alpa Laboratories' alpha and beta are two of the key measurements used to evaluate Alpa Laboratories' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.55 | |||
| Semi Deviation | 3.38 | |||
| Standard Deviation | 3.6 | |||
| Variance | 12.98 |
Alpa Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Alpa Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Alpa Laboratories Corporate Directors
| Vitthal Kothana | Executive Director | Profile | |
| Shitul Shah | Additional Director | Profile | |
| Pravin Shah | Executive Director | Profile | |
| Paresh Chawla | MD Director | Profile |
Additional Tools for Alpa Stock Analysis
When running Alpa Laboratories' price analysis, check to measure Alpa Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpa Laboratories is operating at the current time. Most of Alpa Laboratories' value examination focuses on studying past and present price action to predict the probability of Alpa Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpa Laboratories' price. Additionally, you may evaluate how the addition of Alpa Laboratories to your portfolios can decrease your overall portfolio volatility.